Race, tumor location, and disease progression among low-risk prostate cancer patients.

Justin G MygattJennifer Cullen Samantha A StreicherHuai-Ching KuoYongmei ChenDenise YoungWilliam GesztesGrant WilliamsGalen ContiChristopher PorterSean P StroupKevin R RiceInger L RosnerAllen BurkeIsabell Sesterhenn

Published in: Cancer medicine (2020)

Neither race nor predominant tumor location was associated with adverse oncologic outcome.

Keyphrases

prostate cancer
end stage renal disease
radical prostatectomy
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
rectal cancer
minimally invasive